Sold as Monopril-Hct. Every FDA application for this active ingredient: 1 branded and 9 generic.
As of Nov 16, 2026, FDA lists 10 applications for Fosinopril Sodium; Hydrochlorothiazide (sold as Monopril-Hct), first approved Nov 30, 1994, with 0 new uses approved and 0 published complete response letters.
| Nov 30, 1994 | Monopril-HctNDA 20286 · New combination | Bristol Myers Squibb | 7 | Discontinued |
| Dec 3, 2004 | Fosinopril Sodium And HydrochlorothiazideANDA 76608 | Ani Pharms | 2 | Discontinued |
| Dec 17, 2004 | Fosinopril Sodium And HydrochlorothiazideANDA 76739 | Sun Pharm Inds Ltd | 1 | Discontinued |
| Aug 16, 2005 | Fosinopril Sodium And HydrochlorothiazideANDA 77144 | Ani Pharms | 2 | Discontinued |
| Sep 28, 2005 | Fosinopril Sodium And HydrochlorothiazideANDA 76961 | Sandoz | 4 | Marketed |
| Jul 5, 2006 | Fosinopril Sodium And HydrochlorothiazideANDA 76945 | Teva | 0 | Discontinued |
| Aug 14, 2006 | Fosinopril Sodium And HydrochlorothiazideANDA 77705 | Mylan | 0 | Discontinued |
| Jul 9, 2009 | Fosinopril Sodium And HydrochlorothiazideANDA 79245 | Aurobindo Pharma | 2 | Marketed |
| Jul 9, 2009 | Fosinopril Sodium And HydrochlorothiazideANDA 90228 | Invagen Pharms | 3 | Marketed |
| Sep 17, 2010 | Fosinopril Sodium And HydrochlorothiazideANDA 79025 | Chartwell Rx | 2 | Discontinued |
Applications, approvals and products come from FDA's Drugs@FDA data files, refreshed weekly, grouped by active ingredient as FDA spells it. Complete response letters are FDA's published letters. Medicare spending is CMS's Part D and Part B dashboard, matched to this ingredient by generic name; shortages are FDA's shortage list, matched by application number; clinical trials are ClinicalTrials.gov studies naming the ingredient as an intervention, refreshed daily; safety programs are FDA's REMS list, matched by application number or, for shared programs, by ingredient. Drugs@FDA